INVO Bioscience (INVO) Tops Q2 EPS by 2c
Get Alerts INVO Hot Sheet
Join SI Premium – FREE
INVO Bioscience (NASDAQ: INVO) reported Q2 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $208.5 thousand versus the consensus estimate of $410 thousand.
For earnings history and earnings-related data on INVO Bioscience (INVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
- Super Micro Computer (SMCI) Falls 6%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!